Physiomics (LSE:PYC) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Physiomics Days Payable?

Physiomics's average Accounts Payable for the six months ended in Dec. 2023 was £0.06 Mil. Physiomics's Cost of Goods Sold for the six months ended in Dec. 2023 was £0.00 Mil.

The historical rank and industry rank for Physiomics's Days Payable or its related term are showing as below:

LSE:PYC's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.12
* Ranked among companies with meaningful Days Payable only.

Physiomics's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Physiomics Days Payable Historical Data

The historical data trend for Physiomics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Physiomics Days Payable Chart

Physiomics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

Physiomics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Physiomics's Days Payable

For the Biotechnology subindustry, Physiomics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Physiomics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Physiomics's Days Payable distribution charts can be found below:

* The bar in red indicates where Physiomics's Days Payable falls into.

Physiomics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Physiomics's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (0.027	+	0.018)	/	2 )	/	0	*	365
=	0.0225					/	0	*	365
=	N/A

Physiomics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.018	+	0.105)	/	2 )	/	0	*	365 / 2
=	0.0615					/	0	*	365 / 2
=	N/A

Physiomics Days Payable Related Terms

Thank you for viewing the detailed overview of Physiomics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Physiomics (LSE:PYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Physiomics PLC (LSE:PYC) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

RVW1:Germany

Address

140 Eastern Avenue, Bee House, Milton Park, Oxfordshire, GBR, OX14 4SB

Website

https://www.physiomics.co.uk

Physiomics PLC is a United Kingdom-based firm providing services to pharmaceutical companies through outsourced systems and computational biology. The company is mainly engaged in the development of models to streamline the drug discovery and development process. It focuses to transform oncology drug development. The company operates in the UK, European Union Switzerland and USA.

Physiomics (LSE:PYC) Headlines

No Headlines